Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories, 67360 [2023-21400]
Download as PDF
<![CDATA[
67360
Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before November 28, 2023. Such
persons may also file a written request
for a hearing on the application on or
before November 28, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
DATES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1270]
Bulk Manufacturer of Controlled
Substances Application: Eli-Elsohly
Laboratories
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Eli-Elsohly Laboratories has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
SUMMARY:
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
In
accordance with 21 CFR 1301.33(a), this
is notice that on August 24, 2023, EliElsohly Laboratories, 5 Industrial Park
Drive, Oxford, Mississippi 38655–5343,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
Marihuana Extract ...................................................................................................................................................
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
Amphetamine ..........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
Cocaine ...................................................................................................................................................................
Ecgonine ..................................................................................................................................................................
Codeine ...................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................
Oxycodone ..............................................................................................................................................................
Dihydromorphine .....................................................................................................................................................
Thebaine ..................................................................................................................................................................
The company plans to manufacture
the listed controlled substances for
product development and reference
standards. In reference to drug codes
7360 (Marihuana) and 7370
(Tetrahydrocannabinols), the company
plans to isolate these controlled
substances from procured 7350
(Marihuana Extract). In reference to
drug code 7360, no cultivation activities
are authorized for this registration. In
reference to drug code 9333 (Thebaine),
the company plans to manufacture a
Thebaine derivative. No other activities
for these drug codes are authorized for
this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–21400 Filed 9–28–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
lotter on DSK11XQN23PROD with NOTICES1
Drug Enforcement Administration
[Docket No. DEA–1269]
Importer of Controlled Substances
Application: Maridose LLC
Drug Enforcement
Administration, Justice.
AGENCY:
VerDate Sep<11>2014
22:12 Sep 28, 2023
Jkt 259001
ACTION:
Notice of application.
Maridose LLC. has applied to
be registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 30, 2023. Such
persons may also file a written request
for a hearing on the application on or
before October 30, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
DATES:
PO 00000
Frm 00136
Fmt 4703
Sfmt 4703
Schedule
7350
7360
7370
1100
1105
9041
9180
9050
9120
9143
9145
9333
I
I
I
II
II
II
II
II
II
II
II
II
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on September 12, 2023,
Maridose LLC, 23378 Barlake Drive,
Boca Raton, Florida 33433, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Marihuana Extract ........
Marihuana .....................
Tetrahydrocannabinols
E:\FR\FM\29SEN1.SGM
29SEN1
Drug
code
7350
7360
7370
Schedule
I
I
I
]]>Agencies
[Federal Register Volume 88, Number 188 (Friday, September 29, 2023)]
[Notices]
[Page 67360]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21400]
[[Page 67360]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1270]
Bulk Manufacturer of Controlled Substances Application: Eli-
Elsohly Laboratories
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Eli-Elsohly Laboratories has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
November 28, 2023. Such persons may also file a written request for a
hearing on the application on or before November 28, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 24, 2023, Eli-Elsohly Laboratories, 5
Industrial Park Drive, Oxford, Mississippi 38655-5343, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substance(s):
----------------------------------------------------------------------------------------------------------------
Controlled substance Drug code Schedule
----------------------------------------------------------------------------------------------------------------
Marihuana Extract......................................... 7350 I
Marihuana................................................. 7360 I
Tetrahydrocannabinols..................................... 7370 I
Amphetamine............................................... 1100 II
Methamphetamine........................................... 1105 II
Cocaine................................................... 9041 II
Ecgonine.................................................. 9180 II
Codeine................................................... 9050 II
Dihydrocodeine............................................ 9120 II
Oxycodone................................................. 9143 II
Dihydromorphine........................................... 9145 II
Thebaine.................................................. 9333 II
----------------------------------------------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
for product development and reference standards. In reference to drug
codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company
plans to isolate these controlled substances from procured 7350
(Marihuana Extract). In reference to drug code 7360, no cultivation
activities are authorized for this registration. In reference to drug
code 9333 (Thebaine), the company plans to manufacture a Thebaine
derivative. No other activities for these drug codes are authorized for
this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-21400 Filed 9-28-23; 8:45 am]
BILLING CODE P
